UroToday - Overactive Bladder (OAB)

Home

Overactive Bladder (OAB)

Overactive Bladder

UroToday's Overactive Bladder section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of overactive bladder. Also available are conference coverage for all timely overactive bladder science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.
Kind regards,
Christian Gratzke, MD
Associate Section Editor Overactive Bladder
UroToday International Journal

Display

results per page

Results 181 - 195 of 280

<< Start < Prev 11 12 13 14 15 16 17 18 19 Next > End >>

Intradetrusor Injection of Botulinum-A Toxin in Patients with Idiopathic and Neurogenic Detrusor Overactivity: Urodynamic Outcome and Patient Satisfaction - Abstract
Tuesday, 28 August 2007
Faculty of Medicine, Jordan University of Science & Technology, King Abdullah University Hospital, Irbid, Jordan. ibrahimg@just.edu.jo
read more

Developments in the Pharmacotherapy of the Overactive Bladder - Abstract
Monday, 27 August 2007
Biomedical Research Centre, Sheffield Hallam University, Sheffield, UK. d.j.sellers@shu.ac.uk
read more

LUTS Treatment: Future Treatment Options - Abstract
Friday, 24 August 2007
Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston Salem, North Carolina.
read more

Botulinum Toxin for Detrusor Overactivity and Symptoms of Overactive Bladder: Where We are Now and Where We are Going - Abstract
Thursday, 23 August 2007
Guy's, King's and St Thomas' School of Medicine, London, UK.
read more

Cognitive Dysfunction with Tolterodine Use - Abstract
Wednesday, 22 August 2007
Department of Obstetrics and Gynecology, University of Insubria, Del Ponte Hospital, Varese, Italy. stefanosalvatore@hotmail.com
read more

Treatment Outcomes in the STAR Study: A Subanalysis of Solifenacin 5 mg and Tolterodine ER 4 mg - Abstract
Tuesday, 21 August 2007
Urology Research Office, Royal Hallamshire Hospital, Sheffield, UK.
read more

Long-Term Efficacy of Tolterodine and Patient Compliance in Pediatric Patients with Neurogenic Detrusor Overactivity - Abstract
Tuesday, 21 August 2007
Department of Urology, Charité - Universitatsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
read more

Age Related Pathogenesis of Nocturia in Patients with Overactive Bladder - Abstract
Monday, 20 August 2007
Weill Cornell Medical Center, New York, New York 10021, USA. urojock@aol.com
read more

Long-Term Tolerability of Tolterodine Extended Release in Children 5-11 Years of Age: Results from a 12-Month, Open-Label Study - Abstract
Monday, 20 August 2007
University Medical Centre Groningen, Groningen, The Netherlands.
read more

The Clinical Efficacy of Tolterodine Extended-Release is Maintained for 24 h in Patients with Overactive Bladder - Abstract
Friday, 17 August 2007
Department of Urology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. roger.dmochowski@vanderbilt.edu
read more

The Effects of Tolterodine on Bladder-Filling Sensations and Perception Thresholds to Intravesical Electrical Stimulation: Method and Initial Results - Abstract
Friday, 17 August 2007
Neuro-Urology, Swiss Paraplegic Center, Balgrist University Hospital, Zurich, Switzerland.
read more

Verathon Technology Challenge Award Winners Announced at AUA: Winners from VA Boston/Harvard Honored
Friday, 01 June 2007
read more

AUA 2007 Plenary Session: Presidential Address; “The Survival of Urology: Was Darwin Right?”
Thursday, 24 May 2007
read more

Society of Urologic Nurses and Associates Releases Guide for Nurses New to Operating Room
Tuesday, 24 April 2007
read more

European Urology - Acetylcholine and the Overactive Bladder
Monday, 02 April 2007
Volume 51, Issue 4, Pages 881-883 (April 2007) Currently, the most widely used and effective pharmacologic treatment for the overactive bladder (OAB) is administration of muscarinic receptor antagonists.
read more

Focus on Overactive Bladder

CME Activity

Overactive Bladder Management: Thinking Beyond Urgency and Frequency

New: Poster Presentation
Clinical Proof of Concept Study (BLOSSOM) Shows Novel Beta 3 Adrenoceptor Agonist YM178 is Effective and Well Tolerated in the Treatment of Symptoms of Overactive Bladder

Review
Defining Overactive Bladder as Hypersensitivity

Review
Lower Urinary Tract Symptomatology: Its Definition and Confusion

Review
Overlap of Voiding Symptoms, Storage Symptoms and Pain in Men and Women

Review
Resiniferatoxin and Botulinum Toxin Type A for Treatment of Lower Urinary Tract Symptoms

Abstract
Anticholinergic Drugs Versus Other Medications for Overactive Bladder Syndrome in Adults

Abstract
Long-Term Darifenacin Treatment for Overactive Bladder in Patients Aged 65 Years and Older: Analysis of Results from a 2-Year, Open-Label Extension Study

Overactive Bladder Viewpoints

BJU Int Mini Reviews

- Sacral Neuromodulation for Treating the Symptoms of Overactive Bladder Syndrome and Non-Obstructive Urinary Retention: More Than 10 Years of Clinical Experience

- View

BJU Int Mini Reviews

- Treating Patients with Overactive Bladder Syndrome with Antimuscarinics: Heart Rate Considerations

- View